Zacks Company Profile for Smith & Nephew SNATS, Inc. (SNN : NYSE) |
|
|
|
Company Description |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Number of Employees: 17,349 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $29.77 |
Daily Weekly Monthly
 |
20 Day Moving Average: 854,436 shares |
Shares Outstanding: 437.97 (millions) |
Market Capitalization: $13,038.45 (millions) |
Beta: 0.69 |
52 Week High: $31.72 |
52 Week Low: $23.69 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-0.96% |
-3.93% |
12 Week |
14.37% |
-0.86% |
Year To Date |
21.11% |
14.42% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Deepak Nath - Chief Executive Officer
Rupert Soames - Chairman
John Rogers - Chief Financial Officer
Bob White - Independent Non-Executive Director
Rick Medlock - Independent Non-Executive Director
|
|
Peer Information
Smith & Nephew SNATS, Inc. (BJCT)
Smith & Nephew SNATS, Inc. (CADMQ)
Smith & Nephew SNATS, Inc. (APNO)
Smith & Nephew SNATS, Inc. (UPDC)
Smith & Nephew SNATS, Inc. (IMTIQ)
Smith & Nephew SNATS, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 83175M205
SIC: 3842
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 437.97
Most Recent Split Date: 10.00 (2.50:1)
Beta: 0.69
Market Capitalization: $13,038.45 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 3.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.89 |
Current Fiscal Year EPS Consensus Estimate: $1.96 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 16.57% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: - |
|
|
|
|